Western pharmaceutical companies have invested tens of billions of dollars in Chinese biotechnology companies and licensing agreements to bolster their drug development pipelines

The complex and evolving relationship between the United States and China, encompassing diplomatic, military, economic, and technological dimensions, including tensions over Taiwan, competition in the Indo-Pacific, AI development, and broader questions of global power and deterrence.